96711 ⎘
Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links; Tripeptides with the first amino acid being neutral and aromatic or cycloaliphatic
PRODRUGS OF RILUZOLE AND THEIR METHOD OF USE
#2PRODRUGS OF RILUZOLE AND THEIR METHOD OF USE
#31,2,4-Oxadiazole and Thiadiazole Compounds as Immunomodulators
#4FAP-ACTIVATED PROTEASOME INHIBITORS FOR TREATING SOLID TUMORS
#5RILUZOLE PRODRUGS AND THEIR USE
#6METHODS FOR THE TREATMENT OF MITOCHONDRIAL DISEASE
#7Protease inhibitors
#8AROMATIC-CATIONIC PEPTIDES AND USES OF SAME
#9AROMATIC-CATIONIC PEPTIDES AND USES OF SAME
#10TRANSFECTION COMPLEXES AND METHODS OF USING THE SAME
#11PSMA-TARGETED NIR DYES AND THEIR USES
#12PEPTIDOMIMETIC MATRIPTASE 2 INHIBITORS AND USES THEREOF
#13MODULATORS OF SORTILIN ACTIVITY
#14ANTI-AGING SALMON ROE TRIPEPTIDE AND PREPARATION METHOD AND APPLICATION THEREOF
#15ANTIGENIC TRIPEPTIDES DERIVED FROM MYCOBACTERIUM AVIUM SUBSP. PARATUBERCULOSIS S-TYPE STRAINS, DERIVATIVES AND USES THEREOF
#16FLEXIBLE DRY SPRINKLER HAVING A DIFFERENTIAL PRESSURE CONTROLLER
#17PEPTIDE-COMPOUND CYCLIZATION METHOD
#18THERAPEUTIC PEPTIDES
#19PRODRUGS OF RILUZOLE AND THEIR METHOD OF USE
#20THIOPHOSPHOPEPTIDES FOR ULTRAFAST TARGETING OF THE GOLGI APPARATUS
#21RILUZOLE PRODRUGS AND THEIR USE
#22Riluzole prodrugs and their use
#23Flexible dry sprinkler having a differential pressure controller
#24Cysteine protease inhibitors and methods of use thereof
#25SMALL MOLECULE INHIBITORS OF SARS-CoV-2 VIRAL REPLICATION AND USES THEREOF
#26MACROCYCLIC BROAD SPECTRUM ANTIBIOTICS
#27NOVEL ANTIBACTERIAL HYDROGELS
#281,2,4-Oxadiazole and Thiadiazole Compounds as Immunomodulators
#29Antigenic tripeptides derived from subsp. s-type strains, derivatives and uses thereof
#30Riluzole prodrugs and their use
#31Peptide macrocycles against
#32Prodrugs of riluzole and their method of use
#33Cyclic peptide compound simulating natural product structure, and method for preparation thereof
#34Peptidomimetics for the treatment of coronavirus and picorna virus infections
#35COMPOUNDS FOR PROTEASOME ENZYME INHIBITION
#36Inhibitors of IAP
#37Piezoelectric peptide-based materials and piezoelectric devices containing same
#38Inhibitors for proliferating cell nuclear antigen and uses
#39PSMA-TARGETED NIR DYES AND THEIR USES
#40Transfection complexes and methods of using the same
#41METHOD FOR SYNTHESIZING PEPTIDES
#42PEPTIDE INHIBITORS OF TIGHT JUNCTION PERMEABILITY
#43Humidity-responsive tripeptide crystal
#44FAP-activated proteasome inhibitors for treating solid tumors
#45Heterocyclic amide compounds having an RORvt inhibitory action
#46Riluzole prodrugs and their use
#47PRODRUGS OF RILUZOLE AND THEIR METHOD OF USE
#48Riluzole prodrugs and their use
#49Toll-like receptor 4 (TLR4) inhibitors and use thereof
#50COMPOUNDS FOR PROTEASOME ENZYME INHIBITION
#51Modified antibody and radioactive metal-labelled antibody
#52BIOLOGICALLY ACTIVE C-TERMINAL ARGININE-CONTAINING PEPTIDES
#53AROMATIC-CATIONIC PEPTIDES AND USES OF SAME
#54Modified peptides for use in treating neurodegenerative disorders
#55Peptide-compound cyclization method
#56PSMA-targeted NIR dyes and their uses
#57Aromatic-cationic peptides and uses of same
#58Compositions comprising cyclic peptides derived from an A-beta peptide
#59Hybrid ligand, hybrid biomimetic chromedia and preparing method and use thereof
#60Peptidomimetics for the treatment of coronavirus and picornavirus infections
#61UNIVERSAL ABT COMPOUNDS AND USES THEREOF
#621,2,4-oxadiazole and thiadiazole compounds as immunomodulators
#63Compounds for proteasome enzyme inhibition
#64Proteasome inhibitors
#65FAP-activated proteasome inhibitors for treating solid tumors
#66Therapeutic compositions including frataxin, lactoferrin, and mitochondrial energy generating enzymes, and uses thereof
#67METHOD FOR PRODUCING PEPTIDE COMPOUND
#68Riluzole prodrugs and their use
#69Metal complex forming compound, metal complex compound formed thereof, radioactive drug containing the metal complex compound, and method of using and preparing the metal complex compound
#70Pro-pigmenting peptides
#71Peptide inhibitors of tight junction permeability
#72Methods for the treatment of glaucoma and age-related macular degeneration by a peptide D-TRP-AIB
#73Riluzole prodrugs and their use
#74COMPOUNDS FOR PROTEASOME
#75THERAPEUTIC PEPTIDES
#76AZAINDOLINE COMPOUNDS AS GRANZYME B INHIBITORS
#77COMPOUNDS USEFUL FOR THE TREATMENT AND/OR CARE OF THE SKIN, HAIR, NAILS AND/OR MUCOUS MEMBRANES
#78NOVEL COMPOSITION FOR ORGAN PRESERVATION
#79Antigenic tripeptides derived from subsp. s-type strains, derivatives and uses thereof
#80Heterocyclic amide compounds having RORyT inhibitory action
#81INSULIN A-CHAIN DERIVED PEPTIDE FRAGMENT AND PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING DIABETES OR DIABETIC WOUNDS, CONTAINING THE SAME
#82PEPTIDOMIMETICS AND THEIR USE IN THERAPY
#83Inhibitors of hepatitis C virus
#84METHOD FOR ENHANCING EXTRACELLULAR VESICLE PRODUCTION
#85Peptide macrocycles against
#86Fine-tune modulators of neuronal excitability for neuropsychiatric disorders
#87Fluorohydroxyproline derivatives useful in the preparation of proteolysis targeted chimeras
#88Peptide for coating surfaces
#89Self-assembling peptide polymer
#90Inhibitors of IAP
#91Process for purification of carfilzomib intermediate
#92COMPOUNDS FOR PROTEASOME ENZYME INHIBITION
#93INTRAESOPHAGEAL ADMINISTRATION OF TARGETED NITROXIDE AGENTS FOR PROTECTION AGAINST IONIZING IRRADIATION-INDUCED ESOPHAGITIS
#94N-carboxyanhydride-based-scale synthesis of elamipretide
#95Anti-inflammatory tripeptides
#96PSMA-targeted NIR dyes and their uses
#97Anti-amyloid beta antibodies binding to a cyclic amyloid beta peptide
#98Pro-pigmenting peptides
#99Neuropeptide S receptor (NPSR) agonists
#100AROMATIC-CATIONIC PEPTIDES AND USES OF SAME
#101FAP-activated proteasome inhibitors for treating solid tumors
#102THERAPEUTIC COMPOSITIONS INCLUDING PHENAZINE-3-ONE AND PHENOTHIAZINE-3-ONE DERIVATIVES AND USES THEREOF
#103Inhibitors of hepatitis C virus
#104Trifluoromethylpropanamide derivatives as HTRA1 inhibitors
#105Difluoroketamide derivatives as HtrA1 inhibitors
#106AROMATIC-CATIONIC PEPTIDES AND USES OF SAME
#107Peptide macrocycles against Acinetobacter baumannii
#108Inhibitors for proliferating cell nuclear antigen and uses
#109Antimicrobial peptidomimetics
#110Transfection complexes and methods of using the same
#111MACROCYCLIC BROAD SPECTRUM ANTIBIOTICS
#112Process for the preparation of (2S)-N-((S)-1-((S)-4-methyl-1-((R)-2-methyl oxiran-2-yl)-1-oxopentan-2-ylcarbamoyl)-2-phenylethyl)-2-((S)-2-(2-morpholinoacetamido)-4-phenylbutanamido)-4-methylpentanamide
#113ANTIBIOTIC OLIGOPEPTIDES
#114Use of a cyclic tripeptide for improving cellular energy metabolism
#115Chromogenic And Fluorogenic Peptide Substrates For The Detection Of Serine Protease Activity
#116Methods for assaying palmitoyl protein thioesterase 1 and tripeptidyl peptidase activity in dried blood spots for detection of neuronal ceroid lipofuscinoses in newborns
#117Selective cysteine protease inhibitors and uses thereof
#118Pharmaceutical composition for the prevention and treatment of cardiovascular disease comprising the peptide having the ability to inhibit angiotensin-1 converting enzyme as an active ingredient
#119Inhibition of gliadin peptides
#120Conjugate including peptide molecule capable of self-assembly in cell organelle and pharmaceutical composition for preventing or treating cancer including conjugate
#121NOVEL INHIBITORS OF MAMMALIAN TIGHT JUNCTION OPENING
#122Indoline compounds as granzyme B inhibitors
#1231,2,4-Oxadiazole and thiadiazole compounds as immunomodulators
#124P21-ACTIVATED KINASE INHIBITOR
#125BIOLOGICALLY ACTIVE C-TERMINAL ARGININE-CONTAINING PEPTIDES
#126PSMA—targeted NIR dyes and their uses
#127PSMA-targeted NIR dyes and their uses
#128Assay for high-throughput identification of therapeutic compounds
#129Compounds for enzyme inhibition
#130Self-assembling tripeptides
#131GADD45BETA/MKK7 INHIBITOR FOR THE TREATMENT OF A RESISTANT HAEMATOLOGICAL MALIGNANCY
#132Peptide macrocycles against acinetobacter baumannii
#133Azaindoline compounds as granzyme B inhibitors
#134Therapeutic compositions including frataxin, lactoferrin, and mitochondrial energy generating enzymes, and uses thereof
#135Process for the production of D-arginyl-2,6-dimethyl-L-tyrosyl-L-lysyl-L-phenylalaninamide
#136Discovery of the first selective C5A receptor 2 (C5L2/C5AR2) ligands
#137Process for preparing D-arginyl-2,6-dimethyl-L-tyrosyl-L-lysyl-L-phenylalaninamide
#138Selective caspase inhibitors and uses thereof
#139Amide compound
#140COSMETIC OR PHARMACEUTICAL METHODS FOR THE TREATMENT AND/OR CARE OF THE SKIN AND/OR HAIR USING TRIPEPTIDES CAPABLE OF STIMULATING CYCLIC ADENOSINE MONOPHOSPHATE SYNTHESIS
#141INHIBITION OF GLIADIN PEPTIDES
#142Biologically active C-terminal arginine-containing peptides
#143Macrocyclic broad spectrum antibiotics
#144Pro-pigmenting peptides
#145PSMA-targeted NIR dyes and their uses
#146Device for mooring a water craft to a mooring berth of a pontoon, and corresponding pontoon
#147PSMA-targeted NIR dyes and their uses
#148Methods for the treatment of glaucoma and age-related macular degeneratiion by a peptide D-TRP-AIB
#149Synthetic peptides, enzymatic formation of pericellular hydrogels/nanofibrils, and methods of use
#150Tripeptide epoxyketone compound constructed by heterocycle and preparation method and use thereof
#151Proline compounds as Granzyme B inhibitors
#152Inhibitors of hepatitis C virus
#153FAP-activated proteasome inhibitors for treating solid tumors
#154Antibody that specifically binds partially processed or unprocessed neurotoxin polypeptides
#155Antimicrobial peptidomimetics
#156PEPTIDE-COMPOUND CYCLIZATION METHOD
#157ASSAY FOR INSULIN-DEGRADING ENZYME (IDE) INHIBITORS
#158Photolabile linker for the solid-phase synthesis of hydrazides and pyranopyrazoles
#159Anti-inflammatory tripeptides
#160HCV protease inhibitors and uses thereof
#161Aminostatin derivatives for the treatment of arthrosis
#162NOVEL INHIBITORS OF MAMMALIAN TIGHT JUNCTION OPENING
#163Composition comprising peptide derived from adiponectin
#164Intermediates for macrocyclic compounds
#165Inhibitors of protein tyrosine phosphatases
#166Bifunctional compounds
#167Process for the manufacture of degarelix and its intermediates
#168Compounds
#169INHIBITORS OF HEPATITIS C VIRUS
#170SELF-ASSEMBLED MICRO-AND NANOSTRUCTURES
#171Inhibitors of IAP
#172Proprotein convertase subtilisin kexin type 9 (PCSK9) allosteric binding ligands to modulate serum low density lipoprotein (LDL) levels
#173Indoline compounds as granzyme B inhibitors
#174Synthetic anti-inflammatory peptides and use thereof
#175Liquid automatic dish washing detergent compositions
#176Method for treatment of GM1 gangliosidosis
#177SMALL MOLECULE MODULATORS OF PCSK9 AND METHODS OF USE THEREOF
#178Deprotection method
#179Tunable control of protein degradation in synthetic and endogenous bacterial systems
#180Methods for the treatment of mitochondrial diseases associated with a mutation in or gene resulting in a disruption of mitochondrial oxidative phosphorylation
#181Antifouling materials
#182Gadd45beta targeting agents
#183Compounds for enzyme inhibition
#184Anti-inflammatory proteins and peptides and methods of preparation and use thereof
#185Cysteine arylation directed by a genetically encodable π-clamp
#186PEPTIDE
#187Processes for forming amide bonds and compositions related thereto
#188Solomonamide analogue compounds, pharmaceuticals containing solomonamide analogue compounds, and processes for the preparation thereof
#189Pro-pigmenting peptides
#190HCV NS3 protease inhibitors
#191Inhibitors of protein tyrosine phosphatases
#192INHIBITION OF GLIADIN PEPTIDES
#193Synthesis of telaprevir and boceprevir, or pharmaceutically acceptable salts or solvates as well as intermediate products thereof including β-amino acids prepared via Mukaiyama aldol addition
#194Peptides and use thereof
#195HCV protease inhibitors and uses thereof
#196Pharmaceutical composition for the prevention and treatment of cardiovascular disease comprising the peptide having the ability to inhibit angiotensin-1 converting enzyme as an active ingredient
#197Macrocyclic modulators of the ghrelin receptor
#198AROMATIC-CATIONIC PEPTIDES AND USES OF SAME
#199Compositions containing delta-9-THC-amino acid esters and process of preparation
#200Modulators of protease activated receptors
#201Niacin-peptide having skin whitening activity and use for same
#202Macrocyclic compounds for suppressing replication of hepatitis C virus
#203HCV PROTEASE INHIBITORS AND USES THEREOF
#204Selective caspase inhibitors and uses thereof
#205Organic compounds and their uses
#206IAP BIR domain binding compounds
#207Stabilized subtilisin composition
#208HCV protease inhibitors and uses thereof
#209METHOD FOR THE STEREOSELECTIVE PREPARATION OF AMINO ACID DERIVATIVES
#210Peptidomimetics and their application
#211HCV NS3 protease inhibitors
#212Bifunctional compounds
#213FAP-activated proteasome inhibitors for treating solid tumors
#214Prion protein ligands and methods of use
#215INTRAESOPHAGEAL ADMINISTRATION OF TARGETED NITROXIDE AGENTS FOR PROTECTION AGAINST IONIZING IRRADIATION-INDUCED ESOPHAGITIS
#216Boropeptide inhibitors of enteropeptidase and their uses in treatment of obesity, overweight and/or diseases associated with an abnormal fat metabolism
#217Macrocyclic broad spectrum antibiotics
#218Hepatitis C virus inhibitors
#219METHODS AND COMPOSITIONS FOR TREATING AMYLOID-RELATED DISEASES
#220COMPOUNDS FOR ENZYME INHIBITION
#221Compounds for enzyme inhibition
#222NUCLEIC ACID BINDING COMPOUNDS, METHODS OF MAKING, AND USE THEREOF
#223Compounds for enzyme inhibition
#224NOVEL DIPEPTIDYL PEPTIDASE IV (DP-IV) COMPOUNDS
#225Selective cysteine protease inhibitors and uses thereof
#226Compounds for enzyme inhibition
#227Neuroprotective and neurorestorative methods and compositions
#228Inhibitors of hepatitis C virus
#229Peptides and methods using same for diagnosis and treatment of amyloid-associated disease
#230HCV protease inhibitors and uses thereof
#231Compounds for enzyme inhibition
#232Aminostatin derivatives for the treatment of arthrosis
#233Therapeutic or preventive agent for diabetes
#234Process for the manufacture of Degarelix and its intermediates
#235Peptide
#236Processes and intermediates
#237Inhibitors of the trypsin-like site of the proteasome and methods of use thereof
#238Peptides or Antibodies Which Bind to Melanoma Inhibitory Activity (MIA) Protein
#239IAP BIR domain binding compounds
#240AROMATIC-CATIONIC PEPTIDES AND USES OF SAME
#241Compounds for enzyme inhibition
#242Compounds for enzyme inhibition
#243Compounds for enzyme inhibition
#244Peptidomimetic sulfamide compounds and antiviral uses thereof
#245C-Met receptor regulation by angiotensin IV (AT4) receptor ligands
#246Peptidomimetic sulfamide compounds and antiviral uses thereof
#247HCV protease inhibitors and uses thereof
#248COMPOUNDS FOR PROTEASOME ENZYME INHIBITION
#249OPTIMIZED METHOD FOR OBTAINING ACE ACTIVITY INHIBITORY PEPTIDES FROM WHEY, ACE INHIBITORY PEPTIDES AND FOOD COMPRISING THEM
#250Pyruvamide compounds as inhibitors of dust mite group 1 peptidase allergen and their use
#251Prostaglandin-F2 alpha receptor modulators and uses thereof
#252Gadd45beta targeting agents
#253Compounds For Enzyme Inhibition
#254Process for preparing peptide products for promoting cholecystokinin secretion and use of the peptide products
#255INHIBITORS OF INTERLEUKIN-1 BETA CONVERTING ENZYME
#256Processes for preparing protease inhibitors of hepatitis C virus
#257Organic compounds and their uses
#258PROCESSES FOR INTERMEDIATES FOR MACROCYCLIC COMPOUNDS
#259PROCESSES FOR INTERMEDIATES FOR MACROCYCLIC COMPOUNDS
#260PROCESSES FOR INTERMEDIATES FOR MACROCYCLIC COMPOUNDS
#261Inhibitors of the trypsin-like site of the proteasome and methods of use thereof
#262Modified peptide substrate
#263HCV protease inhibitors and uses thereof
#264Biologically active peptides and their new uses
#265PROCESSES FOR INTERMEDIATES FOR MACROCYCLIC COMPOUNDS
#266BIOLOGICALLY PRODUCED CYCLIC AFFINITY TAGS
#267ANTI-INFLAMMATORY AGENT FOR ORAL APPLICATION, AND ANTI-INFLAMMATORY PEPTIDE FOR ORAL APPLICATION
#268Tripeptide boronic acid or boronic ester, preparative method and use thereof
#269PROCESS FOR THE PURIFICATION OF HUMAN GROWTH HORMONE POLYPEPTIDES USING AFFINITY RESINS COMPRISING SPECIFIC LIGANDS
#270PEPTOID COMPOUNDS
#271Processes for forming amide bonds and compositions related thereto
#272Compounds for enzyme inhibition
#273Compounds for enzyme inhibition
#274Compounds For Enzyme Inhibition
#275Compounds For Enzyme Inhibition
#276Compounds for enzyme inhibition
#277Compounds for enzyme inhibition
#278Compounds for enzyme inhibition
#279Compounds for enzyme inhibition
#280Compounds for enzyme inhibition
#281Inhibitors of protein tyrosine phosphatases
#282Neuroprotective and neurorestorative method and compositions
#283PEPTIDES USED IN THE TREATMENT AND/OR CARE OF THE SKIN AND/OR HAIR AND THEIR USE IN COSMETIC OR PHARMACEUTICAL COMPOSITIONS
#284Inhibitors of serine proteases, particularly HCV NS3-NS4A proteases
#285TUMOR NECROSIS FACTOR INHIBITING PEPTIDES AND USES THEREOF
#286G-TYPE PEPTIDES AND OTHER AGENTS TO AMELIORATE ATHEROSCLEROSIS AND OTHER PATHOLOGIES
#287Means and methods for manufacturing highly pure neurotoxin
#288ANTIOXIDANT AGENT
#289COMPOSITIONS, KITS AND METHODS FOR DETERMINING PLASMIN ACTIVITY
#290Peptidic compounds
#291Cosmetic or pharmaceutical peptides containing uncoded amino acids and their use in the treatment and/or care of the skin, mucous membranes, or scalp
#292Methods of treating cachexia with macrocyclic modulators of the ghrelin receptor
#293Organic compounds and their uses
#294Inhibition of gliadin peptides
#295FUSION PROTEINS COMPRISING DP-178 AND OTHER VIRAL FUSION INHIBITOR PEPTIDES USEFUL FOR TREATING AIDS
#296Compounds and compositions as channel activating protease inhibitors
#297Processes for intermediates for macrocyclic compounds
#298Spatially-defined macrocyclic compounds useful for drug discovery
#299Peptide-containing culture medium for culturing animal cell
#300Biologically active C-terminal arginine-containing peptides